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While stress activates the hypothalamic–pituitary–adrenal (HPA) axis, it suppresses the
hypothalamic–pituitary–gonadal (HPG) axis. Corticotropin-releasing factor (CRF) is a major
regulatory peptide in the HPA axis during stress. Urocortin 1 (Ucn1), a member of the
CRF family of peptides, has a variety of physiological functions and both CRF and Ucn1
contribute to the stress response via G protein-coupled seven transmembrane receptors.
Ucn2 and Ucn3, which belong to a separate paralogous lineage from CRF, are highly
selective for the CRF type 2 receptor (CRF2 receptor). The HPA and HPG axes interact
with each other, and gonadal function and reproduction are suppressed in response to
various stressors. In this review, we focus on the regulation of gonadotropins by CRF
and Ucn2 in pituitary gonadotrophs and of gonadotropin-releasing hormone (GnRH) via
CRF receptors in the hypothalamus. In corticotrophs, stress-induced increases in CRF
stimulate Ucn2 production, which leads to the inhibition of gonadotropin secretion via the
CRF2 receptor in the pituitary. GnRH in the hypothalamus is regulated by a variety of stress
conditions. CRF is also involved in the suppression of the HPG axis, especially the GnRH
pulse generator, via CRF receptors in the hypothalamus. Thus, complicated regulation of
GnRH in the hypothalamus and gonadotropins in the pituitary via CRF receptors contributes
to stress responses and adaptation of gonadal functions.
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INTRODUCTION
A variety of stressors have been shown to suppress gonadal func-
tion (Chand and Lovejoy, 2011). Proteins that play key roles in
vertebrate reproduction include the neuropeptides gonadotropin-
releasing hormone (GnRH) and kisspeptin and their receptors
(Kim et al., 2012): kisspeptin stimulates GnRH release from
hypothalamic GnRH neurons via Gpr54, a G protein-coupled
receptor (Messager et al., 2005), while the gonadal steroid estro-
gen mediates its inhibitory effect on GnRH secretion by acting
on kisspeptin-expressing neurons of the arcuate nucleus (Oakley
et al., 2009; Ohkura et al., 2009). The expression of kisspeptin and
kisspeptin receptormRNA is downregulated by stressors including
restraint, hypoglycemia, and lipopolysaccharide, which suggests
that kisspeptin/kisspeptin receptor signaling plays a critical role
in the transduction of stress-induced suppression of reproduction
(Kinsey-Jones et al., 2009). In fact, kisspeptin–GPR54 signaling
in the arcuate nucleus of the mediobasal hypothalamus is a criti-
cal neural component of the hypothalamic GnRH pulse generator
(Li et al., 2009).
Gonadotropin-inhibitory hormone (GnIH), an RFamide-
related peptide, can also modulate the reproduction of vertebrates
(Ubuka et al., 2008). GnIH neurons interact directly with GnRH
neurons, and the action of GnIH is mediated by a novel G
protein-coupled receptor, Gpr147 (Ubuka et al., 2008). In mice,
higher concentrations of GnIH-like substances are expressed in the
hypothalamus and GnIH reduces GnRH release from the mouse
hypothalamus (Bentley et al., 2010). The glucocorticoid and
corticotropin-releasing factor (CRF) receptors are expressed in
a large population of GnIH/RFamide-related peptide-expressing
cells (Kirby et al., 2009). Glucocorticoids increase the inhibitory
actions of GnIH on GnRH secretion (Kirby et al., 2009), while the
regulationof GnIHvia theCRF receptor remains tobedetermined.
Corticotropin-releasing factor activates and regulates the
hypothalamic–pituitary–adrenal (HPA) axis during stress (Vale
et al., 1981, 1997). Stress-induced CRF synthesis and secretion
from the hypothalamic paraventricular nucleus (PVN) stimulates
adrenocorticotropic hormone (ACTH) release from pituitary cor-
ticotrophs (Gillies et al., 1982; Mouri et al., 1993), which, in turn,
stimulates the release of glucocorticoids from the adrenal glands
(Whitnall, 1993). These glucocorticoids then moderate the stress
response by inhibiting hypothalamic PVN production of CRF
and pituitary production of ACTH (Whitnall, 1993). Urocortin
1 (Ucn1), a 40-amino acid peptide originally cloned from the
Edinger–Westphal nucleus, is a member of the CRF family of pep-
tides (Vaughan et al., 1995). Both CRF and Ucn1 contribute to
stress responses and cardiovascular and gonadal functions via G
protein-coupled seven transmembrane receptors (Vale et al., 1997;
Kageyama et al., 1999a; Suda et al., 2004). CRF exhibits high afﬁn-
ity forCRF type 1 receptor (CRF1 receptor; IC50= 1.6 nM) but not
for CRF type 2b receptor (CRF2b receptor; IC50 = 42 nM), while
Ucn1 exhibits similar afﬁnity for CRF1 receptor (IC50 = 0.16 nM)
and CRF2b receptor (IC50 = 0.86 nM; Jahn et al., 2004). CRF1
receptor is predominately expressed in the brain and pituitary
gland (Chang et al., 1993; Chen et al., 1993; Vita et al., 1993; Potter
et al., 1994). In the pituitary, the CRF1 receptor is mainly expressed
by corticotrophs and is responsible for mediating the effects of
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hypothalamicCRFonACTH secretion in response to stress (Wynn
et al., 1985; Antoni, 1986).
Ucn2 and Ucn3 prohormones were identiﬁed in the human
genome database and in mouse genomic DNA, respectively (Hsu
and Hsueh, 2001; Lewis et al., 2001; Reyes et al., 2001), from
which the identity and existence of endogenous peptides were
predicted (Fekete and Zorrilla, 2007). Ucn2 and Ucn3 are more
similar to each other than to CRF with regard to receptor bind-
ing (Kishimoto et al., 1995; Lovenberg et al., 1995a; Perrin et al.,
1995; Stenzel et al., 1995). Ucn2 exhibits high afﬁnity for CRF2b
receptor (IC50 = 0.25 nM) but low afﬁnity for CRF1 receptor
(IC50 > 350 nM; Jahn et al., 2004). Similarly, Ucn3 binds with
moderate afﬁnity to CRF2b receptor (IC50 = 14 nM), but its spe-
ciﬁc binding to CRF1 receptor is not detectable (IC50 > 2000 nM;
Jahn et al., 2004). It is hypothesized that an ancient gene duplica-
tion event is behind why Ucn1 belongs to the CRF lineage and why
Ucn2 and Ucn3 represent a separate paralogous lineage (Fekete
and Zorrilla, 2007).
The CRF1 receptor is primarily involved in stress responses and
depression, while the CRF2 receptor is believed to mediate “stress-
coping” responses in the brain, such as anxiolysis (Suda et al.,
2004), becausemicedeﬁcient in theCRF2 receptor or treatedwith a
CRF2 receptor antagonist display increased anxiety-like behaviors
and hypersensitive stress responses (Bale et al., 2000). Further-
more, both Ucn2 and Ucn3 act as anorexigenic neuropeptides via
the CRF2 receptor (Fekete et al., 2011; Chao et al., 2012) and Ucn3
regulates glucose-stimulated insulin secretion and energy home-
ostasis (Li et al., 2007). Ucn3 signaling through the CRF2 receptor
is also a critical molecular mediator in the ventromedial nucleus
of the hypothalamus in regulating feeding and peripheral energy
metabolism (Chao et al., 2012).
Corticotropin-releasing factor is involved in the suppression
of the hypothalamic–pituitary–gonadal (HPG) axis (Rivier et al.,
1986), especially the GnRH pulse generator in the hypothala-
mus (Knobil, 1992). Stress profoundly inhibits the reproductive
function by suppressing the pulsatile release of GnRH and con-
sequently luteinizing hormone (LH), at least in part via the
CRF system as well as through the GABAergic system (Lin et al.,
2012). Although CRF and Ucn clearly have potent effects on
the HPG system, their possible roles and how they are regu-
lated have yet to be fully determined. In this review, we focus on
the regulation and the roles of Ucn2 in pituitary gonadotrophs
and discuss the regulation of GnRH via CRF receptors in the
hypothalamus.
REGULATION OF GONADOTROPINS BY CRF AND Ucn2 IN THE
PITUITARY
Changes in CRF1 receptor expression and desensitization of the
receptor in pituitary corticotrophs play a major role in modulating
adaptive responses to stressors (Kageyama et al., 2006). CRF, vaso-
pressin, lipopolysaccharides, cytokines, and glucocorticoids can
negatively modulate the levels of pituitary CRF1 receptor mRNA
(Pozzoli et al., 1996; Sakai et al., 1996; Aubry et al., 1997). However,
CRF2 receptor mRNA is also found in the anterior pituitary and
combined immunohistochemistry and in situ hybridization have
demonstrated that CRF2 receptor mRNA colocalizes mainly with
gonadotrophs, not corticotrophs (Figure 1).
RNase protection assays of anterior pituitary mRNA show that
the dominant receptor type is the CRF type 2a receptor (CRF2a)
receptor and not the CRF2b receptor (Lovenberg et al., 1995a;
Kageyama et al., 2003). Rat CRF2a receptor, linked to various roles
in the brain, is expressed primarily in several discrete brain regions,
including the hypothalamus, lateral septum, and raphe nuclei
(Lovenberg et al., 1995b), whereas the CRF2b receptor is found
predominately in peripheral tissues such as the heart, gastrointesti-
nal tract, arterioles, and muscles (Kageyama et al., 1999b). These
data suggest that the CRF2a receptor in pituitary gonadotrophs
is involved in the modulation of gonadotropin secretion and/or
gonadal function.
Activation of the stress system could potentially inﬂuence
reproduction at any level of the HPG axis (Tilbrook et al., 2002).
The stress-induced decreases in LH/follicle-stimulating hormone
(FSH) secretion inﬂuence gonadal functions such as sex steroido-
genesis and spermproduction (Demura et al., 1989; Tilbrook et al.,
2002). Ucn2 is expressed mainly in corticotrophs of rat pituitary
(Yamauchi et al., 2005), and its secretion and expression levels
are increased by CRF and suppressed by glucocorticoids (Nemoto
et al., 2007).
The CRF2 receptor-selective ligand Ucn2 suppresses both
expression and secretion of gonadotropins in rats, while a CRF2
receptor antagonist increases the secretion of gonadotropins
(Nemoto et al., 2009). In addition, an anti-CRF antibody blocks
stress-induced increases in plasma ACTH and corticosterone, and
an anti-Ucn2 antibody blocks stress-induced suppression of LH
secretion without affecting stress-induced ACTH and corticos-
terone release (Nemoto et al., 2010). Stress-induced increases in
microRNA-325-3p also suppress gonadotropin secretion (Nemoto
et al., 2012). Although the presence and/or secretion of mature
Ucn2 has not been determined in the pituitary or other tissues,
it is possible that stress-induced increases in CRF stimulate Ucn2
in corticotrophs, which inhibits gonadotropin secretion via CRF2
receptors in the pituitary.
REGULATION OF GnRH BY CRF AND Ucn VIA CRF RECEPTORS
IN THE HYPOTHALAMUS
Althoughperipheral administrationof CRF fails to affect LH secre-
tion (D’Agata et al., 1984; Rivier and Vale, 1984), central injection
of CRF inhibits secretion of gonadotropins (Rivier et al., 1986).
These effects of CRF probably reﬂect a central mechanism that
involves modulation of the activity of GnRH neurons in the
hypothalamus (Petraglia et al., 1987; Li et al., 2010). Indeed, in
monkeys, a CRF antagonist attenuates suppression of the GnRH
pulse generator in response to hypoglycemic stress (Chen et al.,
1996). Furthermore, a recent in vivo rat study indicated that CRF
innervation of the dorsolateral bed nucleus of the stria terminalis
plays a central role in stress-induced suppression of the GnRH
pulse generator (Li et al., 2011).
Corticotropin-releasing factor also suppresses GnRH gene
expression levels in murine GnRH GT1-7 cells (Kinsey-Jones et al.,
2006). In fact, GT1-7 GnRH-producing cells have been used
extensively in studies of the basic control mechanisms involved
in GnRH neuronal function. Belsham and colleagues have man-
aged to develop cell lines that are representative of the enormous
range of cell types of the hypothalamus (Dalvi et al., 2011). N39,
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FIGURE 1 | Localization of CRF2 receptor mRNA in the rat anterior
pituitary gland. Representative dark-ﬁeld photomicrographs showing
anterior pituitary sections probed with either antisense (A) or sense
(B) in situ hybridization probes for CRF2 receptor mRNA. Positive signals
(indicated by silver grain clusters) were found only in the tissues probed
with antisense probes; no signals were found in the sense control.
(C) Bright-ﬁeld photomicrograph showing LH-immunoreactive cells in
the rat anterior pituitary. Gonadotrophs (visualized by the brown DAB
precipitate) represent LH-immunoreactive cells. (D) Dark-ﬁeld image
of the same area as panel (C) showing CRF2 receptor mRNA-positive
cells (silver grain clusters). Some of the cells that are double-labeled by
immunostaining for LH and in situ hybridization for CRF2 receptor
mRNA are indicated by arrows. Inset : High-power magniﬁcation of the
boxed area of panel (D) to illustrate a LH-positive cell that shows a
positive signal for CRF2 receptor mRNA (scattered black silver grains). (E)
Representative bright-ﬁeld photomicrograph of the anterior pituitary showing
ACTH-immunoreactive cells (brown DAB precipitate). (F) Dark-ﬁeld image of
the same area as panel (E) showing CRF2 receptor mRNA signals (silver grain
clusters). Only a few ACTH-immunoreactive and CRF2 receptor mRNA
double-labeled cells (arrow ) were observed. Scale bar, 50 μm. Reproduction
from Kageyama et al. (2003) with permission of the publisher. Copyright 2003,
The Endocrine Society.
developed from primary mouse fetal hypothalamic culture, is one
of these homologous neuronal cell lines. To further understand
the possible function of Ucn and the regulation of GnRH by
CRF receptors in the hypothalamus, hypothalamic N39 cells have
been studied because they express both CRF1 and CRF2 receptor
mRNA and protein (Kageyama et al., 2012). It has been shown in
these cells that a CRF1 receptor antagonist, antalarmin, inhibits
CRF-induced decreases in GnRH mRNA levels, which suggests
that CRF decreases GnRH mRNA levels via the CRF1 receptor
(Figure 2).
The CRF2 receptor may also be involved in the regulation of
GnRH gene expression. It has been reported that CRF regulates
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FIGURE 2 | Effects of a CRF receptor antagonist on the effects of CRF
and Ucn2 on GnRH mRNA levels in N39 cells. Cells were pre-incubated
with medium containing 1 μM antalarmin (ANT), antisauvagine-30 (AS), or
vehicle for 30 min, and then incubated for 6 h with medium containing
100 nM CRF, 100 nM Ucn2, or vehicle. Reproduction from Kageyama et al.
(2012) with permission of the publisher. Copyright 2012, Elsevier.
GnRH mRNA levels via, at least in part, the CRF2 receptor
in GT1-7 cells (Kinsey-Jones et al., 2006). In N39 cells, Ucn2
increases GnRH mRNA levels, and these Ucn2-induced increases
inGnRHmRNA levels are blockedby theCRF2 receptor antagonist
antisauvagine-30 (Figure 2). These results suggest that Ucn2 stim-
ulates GnRH mRNA levels via the CRF2 receptor in hypothalamic
cells. In an in vivo study, hypoglycemia- and lipopolysaccharide-
induced suppression of LH involves activation of CRF2 receptor
while restraint stress-induced inhibition of LH pulses involves
both CRF1 and CRF2 receptors (Li et al., 2006). On the other hand,
amore recent in vivo study showed that aCRF1 receptor antagonist
blocks the acute stress-induced increases in gonadotropin secre-
tion on the morning of proestrus while a CRF2 receptor antagonist
weakly blocks the increase in FSH secretion (Traslaviña and Franci,
2012). Although GnRH production and secretion may be differ-
entially modulated via CRF receptors under different stressors,
further study will be required to elucidate the involvement of CRF
receptors.
Glucocorticoids were recently shown to increase CRF2a recep-
tor expression while simultaneously inhibiting CRF1 receptor
expression in pancreatic β cell-derived insulinoma MIN6 cells
expressing glucocorticoid receptors (Huising et al., 2011). The dif-
ferential effects of the glucocorticoids on the expression of these
receptors in the endocrine pancreas represent a mechanism of
shifting sensitivity from CRF1 to CRF2 receptor ligands (Huis-
ing et al., 2011). In the hypothalamus, glucocorticoids, released in
response to stress, inhibit GnRH and gonadotropins through acti-
vation of GnIH (Kirby et al., 2009). It has yet to be determined
whether glucocorticoid-induced changes in CRF and Ucn are
involved in the regulation of GnRH and gonadotropins.
RELATION BETWEEN SEXUAL DIFFERENCES AND THE CRF
SYSTEM IN THE HYPOTHALAMUS
Sexual dimorphism is associated with stress sensitivity and inter-
action of the HPA and HPG axes (Chand and Lovejoy, 2011).
Estrogens are implicated in the differing stress responses between
the sexes and modulate activation of the HPA axis; females,
but not males, generally have slight hypercortisolism (Magiakou
et al., 1997). Estrogen replacement increases the basal levels of
ACTH in ovariectomized rats (Ochedalski et al., 2007) and in post-
menopausal women (Fonseca et al., 2001). Moreover, women in
the midluteal phase, when both progesterone and estrogen levels
are relatively high, show enhanced ACTH levels in response to a
stressor (Altemus et al., 2001).
Estrogens acting centrally, including in the pituitary corti-
cotrophs and the hypothalamus, are able to modulate the stress
responses (Nakano et al., 1991), and direct estrogenic regulation
of CRF gene expression has also been demonstrated in various
tissues (Vamvakopoulos and Chrousos, 1993; Dibbs et al., 1997).
As high levels of estrogen replacement increase the basal levels of
CRF mRNA in the PVN of ovariectomized rats (Ochedalski et al.,
2007), estrogen would regulate the HPA axis in vivo by stimulating
CRF gene expression in the hypothalamus. CRF mRNA levels in
the PVN are not affected by estrogen treatment in either gonadec-
tomized estrogen receptor (ER) type β (ERβ) knockout mice or
wild-type male mice (Nomura et al., 2002). Therefore, it is likely
that estrogen modulates CRF gene expression in a sex-dependent
manner.
Hypothalamic 4B cells show characteristics of the parvocellular
neurons of the PVN because these cells express CRF, vasopressin,
CRF1 receptor, and glucocorticoid receptors. Estrogen directly
stimulates CRF gene expression in hypothalamic 4B cells (Ogura
et al., 2008), suggesting that estrogen is involved in the positive reg-
ulation of CRF gene expression in the parvocellular region of the
PVN in vitro. Neurons expressing both CRF and ERβ are found in
the medial parvocellular division (Miller et al., 2004) and project
to the median eminence, and CRF in parvocellular PVN neu-
rons exerts effects on corticotroph ACTH secretion (Gillies et al.,
1982; Mouri et al., 1993). Therefore, estrogen and ERβ would con-
tribute to the enhancement of stress responses through stimulation
of CRF neurons of the hypothalamus, and may constitute the
basis of sexual dimorphism in the regulation of the CRF gene
(Straub, 2007). In addition, estrogen also enhances CRF- and
stress-induced suppression of pulsatile LH secretion (Cates et al.,
2004), and upregulation of the CRF2 receptor may contribute
to the sensitizing inﬂuence of estradiol on the CRF- and stress-
induced suppression of the GnRH pulse generator (Kinsey-Jones
et al., 2006).
Meanwhile, Ucn1 in the non-preganglionic Edinger–Westphal
nucleus plays an important role in stress adaptation. Estro-
gens exert a differential transcriptional regulation of the Ucn1
gene through either ER type α (ERα) or ERβ receptors (Haeger
et al., 2006). Ucn1 mRNA levels in the non-preganglionic
Edinger–Westphal nucleus of male rats are much higher than
those of females (Derks et al., 2010), and estrogens may
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FIGURE 3 |A schematic model of the regulation of gonadotropins by CRF
and Ucn. Stress-induced increases in CRF stimulate Ucn2 in corticotrophs,
which inhibits gonadotropin secretion via the CRF2 receptor in the pituitary.
CRF inhibits the stress-induced suppression of the GnRH pulse generator and
decreases GnRH mRNA levels via the CRF1 receptor in the hypothalamus.
The CRF2 receptor may also be involved in the regulation of GnRH.
contribute to stress adaptation through modulation of Ucn1
production.
CONCLUSION
In summary, Ucn2, mainly produced in corticotrophs in response
to CRF, acts on gonadotrophs expressing the CRF2 receptor
and inhibits the production of gonadotropins in the pituitary
(Figure 3). CRF is involved in the suppression of the HPG
axis, especially the GnRH pulse generator in the hypothalamus,
and also decreases GnRH mRNA levels via the CRF1 receptor
(Figure 3). The CRF2 receptor may be involved in the regulation
of GnRH production and secretion. GnRH production and secre-
tionmay be differentiallymodulated viaCRF receptors in response
to different stressors. Thus, complicated regulation of GnRH
and gonadotropins via the CRF receptors contributes to stress
responses and adaptation in gonadal functions.
ACKNOWLEDGMENT
This work was supported in part by Health and Labour Sci-
ences Research Grants (Research on Measures for Intractable
Diseases) from the Ministry of Health, Labour, and Welfare of
Japan.
REFERENCES
Altemus, M., Roca, C., Galliven, E.,
Romanos, C., and Deuster, P. (2001).
Increased vasopressin and adreno-
corticotropin responses to stress in
the midluteal phase of the menstrual
cycle. J. Clin. Endocrinol. Metab. 86,
2525–2530.
Antoni, F. A. (1986). Hypothalamic
control of adrenocorticotropin secre-
tion: advances since the discovery
of 41-residue corticotropin-releasing
factor. Endocr. Rev. 7, 351–378.
Aubry, J.-M., Turnbull, A. V., Pozzzoli,
G., Rivier, C., and Vale, W. (1997).
Endotoxin decreases corticotropin-
releasing factor receptor 1 messenger
ribonucleic acid levels in rat pituitary.
Endocrinology 138, 1621–1626.
Bale, T. L., Contarino, A., Smith,
G. W., Chan, R., Gold, L. H.,
Sawchenko, P. E., et al. (2000). Mice
deﬁcient for corticotropin-releasing
hormone receptor-2 display anxiety-
like behaviour and are hypersen-
sitive to stress. Nat. Genet. 24,
410–414.
Bentley, G. E., Tsutsui, K., and Kriegs-
feld, L. J. (2010). Recent stud-
ies of gonadotropin-inhibitory hor-
mone (GnIH) in the mammalian
hypothalamus, pituitary and gonads.
Brain Res. 1364, 62–71.
Cates, P. S., Li, X. F., and O’Byrne,
K. T. (2004). The inﬂuence of
17beta-oestradiol on corticotrophin-
releasing hormone induced suppres-
sion of luteinising hormone pulses
and the role of CRH in hypogly-
caemic stress-induced suppression of
pulsatile LH secretion in the female
rat. Stress 7, 113–118.
Chand, D., and Lovejoy, D. A.
(2011). Stress and reproduction:
controversies and challenges. Gen.
Comp. Endocrinol. 171, 253–257.
Chang, C. P., Pearse, R. I., O’Connell, S.,
and Rosenfeld, M. G. (1993). Iden-
tiﬁcation of a seven transmembrane
helix receptor for corticotropin-
releasing factor and sauvagine in
mammalian brain. Neuron 11, 1187–
1195.
Chao, H., Digruccio, M., Chen, P., and
Li, C. (2012). Type 2 corticotropin-
releasing factor receptor in the ven-
tromedial nucleus of hypothalamus is
critical in regulating feeding and lipid
metabolism in white adipose tissue.
Endocrinology 153, 166–176.
Chen, M. D., Ordög, T., O’Byrne,
K. T., Goldsmith, J. R., Con-
naughton, M. A., and Knobil, E.
(1996). The insulin hypoglycemia-
induced inhibition of gonadotropin-
releasing hormone pulse generator
activity in the rhesus monkey: roles
of vasopressin and corticotropin-
releasing factor. Endocrinology 137,
2012–2021.
Chen, R., Lewis, K. A., Perrin, M. H.,
and Vale, W. W. (1993). Expression
cloning of a human corticotropin-
releasing-factor receptor. Proc. Natl.
Acad. Sci. U.S.A. 90, 8967–8971.
D’Agata, R., Cavagnini, F., Invitti, C.,
Mongioi, A., Fossati, R., Scapagnini,
U., et al. (1984). Effect of CRF
on the release of anterior pituitary
hormones in normal subjects and
patients withCushing’s disease. Phar-
macol. Res. Commun. 16, 303–311.
Dalvi, P. S., Nazarians-Armavil, A.,
Tung, S., and Belsham, D. D. (2011).
Immortalized neurons for the study
of hypothalamic function. Am. J.
Physiol. Regul. Integr. Comp. Physiol.
300, R1030–R1052.
www.frontiersin.org February 2013 | Volume 4 | Article 12 | 5
“fendo-04-00012” — 2013/2/18 — 18:53 — page 6 — #6
Kageyama Regulation of gonadotropin
Demura, R., Suzuki, T., Nakamura,
S., Komatsu, H., Odagiri, E., and
Demura, H. (1989). Effect of immo-
bilization stress on testosterone and
inhibin in male rats. J. Androl. 10,
210–213.
Derks, N. M., Gaszner, B., Roubos, E.
W., and Kozicz, L. T. (2010). Sex
differences in urocortin 1 dynamics
in the non-preganglionic Edinger–
Westphal nucleus of the rat. Neurosci.
Res. 66, 117–123.
Dibbs, K. I., Anteby, E., Mallon, M. A.,
Sadovsky, Y., and Adler, S. (1997).
Transcriptional regulation of human
placental corticotropin-releasing fac-
tor by prostaglandins and estradiol.
Biol. Reprod. 57, 1285–1292.
Fekete, E.M., Zhao,Y., Szücs,A., Sabino,
V., Cottone, P., Rivier, J., et al. (2011).
Systemic urocortin 2, but not uro-
cortin 1 or stressin 1-A, suppresses
feeding via CRF2 receptors without
malaise and stress. Br. J. Pharmacol.
164, 1959–1975.
Fekete, E. M., and Zorrilla, E. P. (2007).
Physiology, pharmacology, and ther-
apeutic relevance of urocortins in
mammals: ancient CRF paralogs.
Front. Neuroendocrinol. 28, 1–27.
Fonseca, E., Basurto, L., Velazquez,
S., and Zarate, A. (2001). Hor-
mone replacement therapy increases
ACTH/dehydroepiandrosterone sul-
fate in menopause. Maturitas 39,
57–62.
Gillies, G. E., Linton, E. A., and Lowry,
P. J. (1982). Corticotropin releasing
activity of the new CRF is potentiated
several times by vasopressin. Nature
299, 355–357.
Haeger, P., Andrés, M. E., Forray, M. I.,
Daza, C., Araneda, S., and Gysling, K.
(2006). Estrogen receptors alpha and
beta differentially regulate the tran-
scriptional activity of the urocortin
gene. J. Neurosci. 26, 4908–4916.
Hsu, S. Y., and Hsueh, A. J. (2001).
Human stresscopin and stresscopin-
related peptide are selective ligands
for the type 2 corticotropin-releasing
hormone receptor. Nat. Med. 7,
605–611.
Huising, M. O., Pilbrow, A. P., Mat-
sumoto, M., van der Meulen, T., Park,
H., Vaughan, J. M., et al. (2011).
Glucocorticoids differentially regu-
late the expression of CRFR1 and
CRFR2α in MIN6 insulinoma cells
and rodent islets. Endocrinology 152,
138–150.
Jahn, O., Tezval, H., van Wer-
ven, L., Eckart, K., and Spiess,
J. (2004). Three-amino acid motifs
of urocortin II and III deter-
mine their CRF receptor subtype
selectivity. Neuropharmacology 47,
233–242.
Kageyama, K., Bradbury, M. J., Zhao,
L., Blount, A. L., and Vale, W.
W. (1999a). Urocortin messenger
ribonucleic acid: tissue distribution
in the rat and regulation in thymus
by lipopolysaccharide and glucocor-
ticoids. Endocrinology 140, 5651–
5658.
Kageyama, K., Gaudriault, G. E., Brad-
bury, M. J., and Vale, W. W. (1999b).
Regulation of corticotropin-releasing
factor receptor type 2 β messenger
ribonucleic acid in the rat cardiovas-
cular system by urocortin, glucocor-
ticoids, and cytokines. Endocrinology
141, 2285–2293.
Kageyama, K., Hanada, K., Moriyama,
T., Nigawara, T., Sakihara, S., and
Suda, T. (2006). G protein-coupled
receptor kinase 2 involvement in
desensitization of corticotropin-
releasing factor (CRF) receptor type
1 by CRF in murine corticotrophs.
Endocrinology 147, 441–450.
Kageyama, K., Hasegawa, G., Aki-
moto, K., Yamagata, S., Tamasawa,
N., and Suda, T. (2012). Differential
regulation of gonadotropin-releasing
hormone by corticotropin-releasing
factor family peptides in hypothala-
mic N39 cells. Peptides 33, 149–155.
Kageyama, K., Li, C., and Vale, W. W.
(2003). Corticotropin-releasing fac-
tor receptor type 2messenger ribonu-
cleic acid in rat pituitary: localization
and regulation by immune challenge,
restraint stress, and glucocorticoids.
Endocrinology 144, 1524–1532.
Kim, D. K., Cho, E. B., Moon, M. J.,
Park, S., Hwang, J. I., Do Rego, J.
L., et al. (2012). Molecular coevolu-
tion of neuropeptides gonadotropin-
releasing hormone and kisspeptin
with their cognate G protein-coupled
receptors. Front. Neurosci. 6:3. doi:
10.3389/fnins.2012.00003
Kinsey-Jones, J. S., Li, X. F., Bowe, J.
E., Lightman, S. L., and O’Byrne, K.
T. (2006). Corticotrophin-releasing
factor type 2 receptor-mediated sup-
pression of gonadotrophin-releasing
hormone mRNA expression in GT1-
7 cells. Stress 9, 215–222.
Kinsey-Jones, J. S., Li, X. F., Knox,
A. M., Wilkinson, E. S., Zhu, X.
L., Chaudhary, A. A., et al. (2009).
Down-regulation of hypothalamic
kisspeptin and its receptor, Kiss1r,
mRNA expression is associated with
stress-induced suppression of lutein-
ising hormone secretion in the
female rat. J. Neuroendocrinol. 21,
20–29.
Kirby, E. D., Geraghty, A. C., Ubuka,
T., Bentley, G. E., and Kaufer,
D. (2009). Stress increases putative
gonadotropin inhibitory hormone
and decreases luteinizing hormone in
male rats. Proc. Natl. Acad. Sci. U.S.A.
106, 11324–11329.
Kishimoto, T., Pearse, R. V. II, Lin, C.
R., and Rosenﬁeld, M. G. (1995).
A sauvagine/corticotropin-releasing
factor receptor expressed in heart and
skeletal muscle. Proc. Natl. Acad. Sci.
U.S.A. 92, 1108–1112.
Knobil, E. (1992). Remembrance:
the discovery of the hypothalamic
gonadotropin-releasing hormone
pulse generator and of its physiolog-
ical signiﬁcance. Endocrinology 131,
1005–1006.
Lewis, K., Li, C., Perrin, M. H., Blount,
A., Kunitake, K., Donaldson, C., et al.
(2001). Identiﬁcation of urocortin
III, an additional member of the
corticotropin-releasing factor (CRF)
family with high afﬁnity for the CRF2
receptor. Proc. Natl. Acad. Sci. U.S.A.
98, 7570–7575.
Li, C., Chen, P., Vaughan, J., Lee,
K. F., and Vale, W. (2007). Uro-
cortin 3 regulates glucose-stimulated
insulin secretion and energy home-
ostasis. Proc. Natl. Acad. Sci. U.S.A.
104, 4206–4211.
Li, X. F., Bowe, J. E., Kinsey-Jones,
J. S., Brain, S. D., Lightman, S. L.,
and O’Byrne, K. T. (2006). Differen-
tial role of corticotrophin-releasing
factor receptor types 1 and 2 in
stress-induced suppression of pul-
satile luteinising hormone secretion
in the female rat. J. Neuroendocrinol.
18, 602–610.
Li, X. F., Kinsey-Jones, J. S., Cheng,
Y., Knox, A. M., Lin, Y., Petrou, N.
A., et al. (2009). Kisspeptin signalling
in the hypothalamic arcuate nucleus
regulates GnRH pulse generator fre-
quency in the rat. PLoS ONE 4:e8334.
doi: 10.1371/journal.pone.0008334
Li, X. F., Knox, A. M., and O’Byrne, K.
T. (2010). Corticotrophin-releasing
factor and stress-induced inhibition
of the gonadotrophin-releasing hor-
mone pulse generator in the female.
Brain Res. 1364, 153–163.
Li, X. F., Lin, Y. S., Kinsey-Jones, J. S.,
Milligan, S. R., Lightman, S. L., and
O’Byrne, K. T. (2011). The role of
the bed nucleus of the stria terminalis
in stress-induced inhibition of pul-
satile luteinising hormone secretion
in the female rat. J. Neuroendocrinol.
23, 3–11.
Lin, Y. S., Li, X. F., Shao, B., Hu,
M. H., Goundry, A. L., Jeyaram, A.,
et al. (2012). The role of GABAer-
gic signalling in stress-induced sup-
pression of gonadotrophin-releasing
hormone pulse generator frequency
in female rats. J. Neuroendocrinol. 24,
477–488.
Lovenberg, T. W., Chalmers, D. T., Liu,
C., and De Souza, E. B. (1995a). CRF
2 α and CRF2 β receptor mRNAs
are differentially distributed between
the rat central nervous system and
peripheral tissues. Endocrinology 136,
4139–4142.
Lovenberg, T. W., Liaw, C. W., Grigori-
adis, D. E., Clevenger, W., Chalmers,
D. T., De Souza, E. B., et al. (1995b).
Cloning and characterization of a
functionally distinct corticotropin-
releasing factor receptor subtype
from rat brain. Proc. Natl. Acad. Sci.
U.S.A. 92, 836–840.
Magiakou, M. A., Mastorakos, G., Web-
ster, E., and Chrousos, G. P. (1997).
The hypothalamic–pituitary–adrenal
axis and the female reproductive sys-
tem. Ann. N. Y. Acad. Sci. 816,
42–56.
Messager, S., Chatzidaki, E. E., Ma, D.,
Hendrick, A. G., Zahn, D., Dixon, J.,
et al. (2005). Kisspeptin directly stim-
ulates gonadotropin-releasing hor-
mone release via G protein-coupled
receptor 54. Proc. Natl. Acad. Sci.
U.S.A. 102, 1761–1766.
Miller, W. J., Suzuki, S., Miller, L.
K., Handa, R., and Uht, R. M.
(2004). Estrogen receptor (ER) beta
isoforms rather than ERalpha regu-
late corticotropin-releasing hormone
promoter activity through an alter-
nate pathway. J. Neurosci. 24, 10628–
10635.
Mouri, T., Itoi, K., Takahashi, K.,
Suda, T., Murakami, O., Yoshi-
naga, K., et al. (1993). Colocalization
of corticotropin-releasing factor and
vasopressin in the paraventricular
nucleus of the human hypothalamus.
Neuroendocrinology 57, 34–39.
Nakano, Y., Suda, T., Sumitomo,
T., Tozawa, F., and Demura, H.
(1991). Effects of sex steroids onbeta-
endorphin release from rat hypotha-
lamus in vitro. Brain Res. 553, 1–3.
Nemoto, T., Iwasaki-Sekino, A.,
Yamauchi, N., and Shibasaki, T.
(2007). Regulation of the expression
and secretion of urocortin 2 in rat
pituitary. J. Endocrinol. 192, 443–452.
Nemoto, T., Iwasaki-Sekino, A.,
Yamauchi, N., and Shibasaki, T.
(2010). Role of urocortin 2 secreted
by the pituitary in the stress-induced
suppression of luteinizing hormone
secretion in rats. Am. J. Phys-
iol. Endocrinol. Metab. 299, E567–
E575.
Nemoto, T., Mano, A., and Shibasaki, T.
(2012). Increased expression of miR-
325-3p by urocortin 2 and its involve-
ment in stress-induced suppression
of LH secretion in rat pituitary. Am.
J. Physiol. Endocrinol. Metab. 302,
E781–E787.
Nemoto, T., Yamauchi, N., and
Shibasaki, T. (2009). Novel action
Frontiers in Endocrinology | Neuroendocrine Science February 2013 | Volume 4 | Article 12 | 6
“fendo-04-00012” — 2013/2/18 — 18:53 — page 7 — #7
Kageyama Regulation of gonadotropin
of pituitary urocortin 2 in the reg-
ulation of expression and secretion
of gonadotropins. J. Endocrinol. 201,
105–114.
Nomura, M., McKenna, E., Korach,
K. S., Pfaff, D. W., and Ogawa, S.
(2002). Estrogen receptor-beta regu-
lates transcript levels for oxytocin and
arginine vasopressin in the hypotha-
lamic paraventricular nucleus of male
mice. Brain Res. Mol. Brain Res. 109,
84–94.
Oakley, A. E., Clifton, D. K., and Steiner,
R. A. (2009). Kisspeptin signaling in
the brain. Endocr. Rev. 30, 713–743.
Ochedalski, T., Subburaju, S., Wynn, P.
C., and Aguilera, G. (2007). Interac-
tion between oestrogen and oxytocin
on hypothalamic–pituitary–adrenal
axis activity. J. Neuroendocrinol. 19,
189–197.
Ogura, E., Kageyama, K., Hanada,
K., Kasckow, J., and Suda, T.
(2008). Effects of estradiol on regula-
tion of corticotropin-releasing factor
gene and interleukin-6 production
via estrogen receptor type beta in
hypothalamic 4B cells. Peptides 29,
456–464.
Ohkura, S., Uenoyama, Y., Yamada,
S., Homma, T., Takase, K., Inoue,
N., et al. (2009). Physiological role
of metastin/kisspeptin in regulat-
ing gonadotropin-releasing hormone
(GnRH) secretion in female rats. Pep-
tides 30, 49–56.
Perrin, M., Donaldson, C., Chen, R.,
Blount, A., Berggren, T., Bilezikjian,
L., et al. (1995). Identiﬁcation of a
second CRF receptor gene and char-
acterization of a cDNA expressed in
heart. Proc. Natl. Acad. Sci. U.S.A. 92,
2969–2973.
Petraglia, F., Sutton, S., Vale, W., and
Plotsky, P. (1987). Corticotropin-
releasing factor decreases plasma
luteinizing hormone levels in female
rats by inhibiting gonadotropin-
releasing hormone release into
hypophysial-portal circulation.
Endocrinology 120, 1083–1088.
Potter, E., Sutton, S., Donaldson,
C., Chen, R., Perrin, M., Lewis,
K., et al. (1994). Distribution of
corticotropin-releasing factor recep-
tor mRNA expression in the rat brain
and pituitary. Proc. Natl. Acad. Sci.
U.S.A. 91, 8777–8781.
Pozzoli, G., Bilezikjian, L. M., Perrin,
M. H., Blount, A. L., and Vale, W. W.
(1996). Corticotropin-releasing fac-
tor (CRF) and glucocorticoids mod-
ulate the expression of type 1 CRF
receptor messenger ribonucleic acid
in rat anterior pituitary cell cultures.
Endocrinology 137, 65–71.
Reyes, T. M., Lewis, K., Perrin, M. H.,
Kunitake, K. S., Vaughan, J., Arias, C.
A., et al. (2001). Urocortin II: a mem-
ber of the corticotropin-releasing fac-
tor (CRF) neuropeptide family that
is selectively bound by type 2 CRF
receptors. Proc. Natl. Acad. Sci. U.S.A.
98, 2843–2848.
Rivier, C., Rivier, J., andVale,W. (1986).
Stress-induced inhibition of repro-
ductive functions: role of endoge-
nous corticotropin-releasing factor.
Science 231, 607–609.
Rivier, C., and Vale, W. (1984). Inﬂu-
ence of corticotropin-releasing factor
on reproductive functions in the rat.
Endocrinology 114, 914–921.
Sakai, K., Horiba, N., Sakai, Y.,
Tozawa, F., Demura, H., and Suda, T.
(1996). Regulation of corticotropin-
releasing factor receptor messen-
ger ribonucleic acid in rat anterior
pituitary. Endocrinology 137, 1758–
1763.
Stenzel, P., Kesterson, R., Yeung, W.,
Cone, R. D., Rittenberg, M. B.,
and Stenzel-Poore, M. P. (1995).
Identiﬁcation of a novel murine
receptor for corticotropin-releasing
hormone expressed in the heart. Mol.
Endocrinol. 9, 637–645.
Straub, R. H. (2007). The complex role
of estrogens in inﬂammation. Endocr.
Rev. 28, 521–574.
Suda, T., Kageyama,K., Sakihara, S., and
Nigawara, T. (2004). Physiological
roles of urocortins, human homo-
logues of ﬁsh urotensin 1, and their
receptors. Peptides 25, 1689–1701.
Tilbrook, A. J., Turner, A. I., and Clarke,
I. J. (2002). Stress and reproduction:
central mechanisms and sex differ-
ences in non-rodent species. Stress 5,
83–100.
Traslaviña, G. A., and Franci, C.
R. (2012). Divergent roles of the
CRH receptors in the control of
gonadotropin secretion induced by
acute restraint stress at proestrus.
Endocrinology 153, 4838–4848.
Ubuka, T., Kim, S., Huang, Y.
C., Reid, J., Jiang, J., Osugi,
T., et al. (2008). Gonadotropin-
inhibitory hormone neurons interact
directly with gonadotropin-releasing
hormone-I and -II neurons in Euro-
pean starling brain. Endocrinology
149, 268–278.
Vale, W., Spiess, J., Rivier, C., and Riv-
ier, J. (1981). Characterization of a
41-residue ovine hypothalamic pep-
tide that stimulates secretion of corti-
cotropin andbeta-endorphin. Science
213, 1394–1397.
Vale, W., Vaughan, J., and Perrin, M.
H. (1997). Corticotropin-releasing
factor (CRF) family ligands and
their receptors. Endocrinologist 7,
3S–9S.
Vamvakopoulos, N. C., and Chrousos,
G. P. (1993). Evidence of direct estro-
genic regulation of human corti-
cotropin-releasing hormone gene
expression. Potential implications for
the sexual dimorphism of the stress
response and immune/inﬂammatory
reaction. J. Clin. Invest. 92, 1896–
1902.
Vaughan, J., Donaldson, C., Bittencourt,
J., Perrin, M. H., Lewis, K., Sut-
ton, S., et al. (1995). Urocortin, a
mammalian neuropeptide related to
ﬁsh urotensin I and to corticotropin-
releasing factor. Nature 378, 287–292.
Vita, N., Laurent, P., Lefort, S.,
Chalon, P., Lelias, J. M., Kaghad,
M., et al. (1993). Primary structure
and functional expression of mouse
pituitary and human brain corti-
cotrophin releasing factor receptors.
FEBS Lett. 335, 1–5.
Whitnall, M. H. (1993). Regulation
of the hypothalamic corticotropin-
releasing hormone neurosecretory
system. Prog. Neurobiol. 40, 573–629.
Wynn, P. C., Harwood, J. P., Catt, K.
J., and Aguilera, G. (1985). Regula-
tion of corticotropin-releasing factor
(CRF) receptors in the rat pitu-
itary gland: effects of adrenalectomy
on CRF receptors and corticotroph
responses. Endocrinology 116, 1653–
1659.
Yamauchi, N., Otagiri, A., Nemoto,
T., Sekino, A., Oono, H., Kato, I.,
et al. (2005). Distribution of uro-
cortin 2 in various tissues of the rat.
J. Neuroendocrinol. 17, 656–663.
Conflict of Interest Statement: The
author declares that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 09 May 2012; accepted: 30 Jan-
uary 2013; published online: 20 February
2013.
Citation: Kageyama K (2013) Regula-
tion of gonadotropins by corticotropin-
releasing factor and urocortin. Front.
Endocrin. 4:12. doi: 10.3389/fendo.2013.
00012
This article was submitted to Frontiers
in Neuroendocrine Science, a specialty of
Frontiers in Endocrinology.
Copyright © 2013 Kageyama. This is
an open-access article distributed under
the terms of the Creative Commons
Attribution License, which permits use,
distribution and reproduction in other
forums, provided the original authors and
source are credited and subject to any
copyright notices concerning any third-
party graphics etc.
www.frontiersin.org February 2013 | Volume 4 | Article 12 | 7
